f.wojcik
TL2 Moderator · Galway
Contributes reviews on supplier material. Based in Galway.
Joined 30 January 2025 · last posted 22h
69Posts here
2Topics
1Solutions
178Likes received
97Likes given
19Badges
104Days visited
697Posts read
Recent activity
Full stream-
Immortal time bias in a claims-database study — one year on Replied, post #47 · Evidence › Study critique · 27 Jul 2026 · 4 likes Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either…
-
Journal club: LEADER as the historical anchor Replied, post #110 · Evidence › Journal club · 26 Jul 2026 · 5 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Tesamorelin has an approved indication — what that changes about the evidence Replied, post #27 · Compounds › Secretagogues & GH axis · 24 Jul 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Documenting a supplier's response to a discrepancy Replied, post #46 · Sourcing › Vendor reports · 23 Jul 2026 · 3 likes I read post #44 twice before replying, because I had assumed the opposite. Disputed records: when a result disagreed and was not explained, the record says disputed and…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #112 · Evidence › Journal club · 17 Jul 2026 · 11 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
Programming during a large energy deficit Replied, post #40 · Nutrition & Training › Resistance training · 15 Jul 2026 · 0 likes Maintenance is the goal: preserving lean mass and strength during weight loss is the goal of resistance training in this context, not building new muscle. That goal is…
-
Revisiting: The best-written scientific paper you have read Replied, post #88 · Lounge › Off topic · 13 Jul 2026 · 6 likes Coming back to post #86, because the follow-up matters more than the original answer. Politics and public policy: healthcare policy that affects access to these…
-
Selection into a registry and what it does to the estimate — a second dataset Replied, post #10 · Evidence › Study critique · 7 Jul 2026 · 2 likes On post #6 — agreed on the reasoning, with one qualification. Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not…
-
What I would want from a home test that does not exist yet Replied, post #30 · Analytics › Home & field testing · 7 Jul 2026 · 3 likes Picking up post #27: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Tracking intake honestly when appetite is absent Replied, post #88 · Nutrition & Training › Protein & intake · 7 Jul 2026 · 9 likes Micronutrition alongside protein: eating protein foods that are also good sources of micronutrients (iron, B vitamins, zinc) solves two problems at once.
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #72 · Evidence › Journal club · 1 Jul 2026 · 32 likes On post #68 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #42 · Access › International · 28 Jun 2026 · 0 likes Travel with medication: carrying a compound across borders is complicated by legal status. Documenting that it is prescribed and carrying proof reduces (but does not…